glp-1 user Some Users Are Scaling Back Their Dose, Should You? GLP-1 Drugs Show Promise, But

The 5-year KFRE was developed and validated in Canada, including for people with diabetes, and is widely available through online resources and in standard lab reports in many regions [3743]

While the GLP-1RA drugs have traditionally been used in type 2 diabetics, their ability to cause weight loss has captured the minds and imaginations of patients, providers, and drug manufacturers alike

This shift is not just about the numbersits changing how physicians and patients think about managing T2D and its many related comorbidities

The short answer is that you may be able to take them together, but you must do so only under the strict supervision of a licensed healthcare provider